{"id":"https://openalex.org/W4404547014","doi":"https://doi.org/10.1111/dom.16076","title":"Glucagon\u2010like peptide 1 ( GLP1 ) receptor agonists and risk for ischemic optic neuropathy: A meta\u2010analysis of randomised controlled trials","display_name":"Glucagon\u2010like peptide 1 ( GLP1 ) receptor agonists and risk for ischemic optic neuropathy: A meta\u2010analysis of randomised controlled trials","publication_year":2024,"publication_date":"2024-11-20","ids":{"openalex":"https://openalex.org/W4404547014","doi":"https://doi.org/10.1111/dom.16076","pmid":"https://pubmed.ncbi.nlm.nih.gov/39563616","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11701179"},"language":"en","primary_location":{"id":"doi:10.1111/dom.16076","doi":"https://doi.org/10.1111/dom.16076","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.16076","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.16076","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.16076","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000249976","display_name":"Giovanni Antonio Silverii","orcid":"https://orcid.org/0000-0002-6695-3213","observed_orcids":["https://orcid.org/0000-0002-6695-3213"]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Giovanni Antonio Silverii","raw_affiliation_strings":["Experimental and Clinical Biomedical Sciences \u2018Mario Serio\u2019 Department University of Florence  Florence Italy"],"raw_orcid":"https://orcid.org/0000-0002-6695-3213","affiliations":[{"raw_affiliation_string":"Experimental and Clinical Biomedical Sciences \u2018Mario Serio\u2019 Department University of Florence  Florence Italy","institution_ids":["https://openalex.org/I45084792"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080271286","display_name":"Laura Pala","orcid":"https://orcid.org/0000-0002-0111-9869","observed_orcids":["https://orcid.org/0000-0002-0111-9869"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Laura Pala","raw_affiliation_strings":["Diabetology Unit AOU Careggi  Florence Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetology Unit AOU Careggi  Florence Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075940000","display_name":"Barbara Cresci","orcid":"https://orcid.org/0000-0002-8730-0748","observed_orcids":["https://orcid.org/0000-0002-8730-0748"]},"institutions":[{"id":"https://openalex.org/I4210115393","display_name":"Azienda Ospedaliero-Universitaria Careggi","ror":"https://ror.org/02crev113","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210115393"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Barbara Cresci","raw_affiliation_strings":["Diabetology Unit AOU Careggi  Florence Italy"],"raw_orcid":"https://orcid.org/0000-0002-8730-0748","affiliations":[{"raw_affiliation_string":"Diabetology Unit AOU Careggi  Florence Italy","institution_ids":["https://openalex.org/I4210115393"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059685674","display_name":"Edoardo Mannucci","orcid":"https://orcid.org/0000-0001-9759-9408","observed_orcids":["https://orcid.org/0000-0001-9759-9408"]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Edoardo Mannucci","raw_affiliation_strings":["Experimental and Clinical Biomedical Sciences \u2018Mario Serio\u2019 Department University of Florence  Florence Italy"],"raw_orcid":"https://orcid.org/0000-0001-9759-9408","affiliations":[{"raw_affiliation_string":"Experimental and Clinical Biomedical Sciences \u2018Mario Serio\u2019 Department University of Florence  Florence Italy","institution_ids":["https://openalex.org/I45084792"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5000249976"],"corresponding_institution_ids":["https://openalex.org/I45084792"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":13.822,"has_fulltext":true,"cited_by_count":50,"citation_normalized_percentile":{"value":0.99335024,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"27","issue":"2","first_page":"1005","last_page":"1009"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9340999722480774,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9340999722480774,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.02250000089406967,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.01140000019222498,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9380000233650208},{"id":"https://openalex.org/keywords/ischemic-optic-neuropathy","display_name":"ischemic optic neuropathy","score":0.9190000295639038},{"id":"https://openalex.org/keywords/non-arteritic-anterior-ischemic-optic-neuropathy","display_name":"nonarteritic anterior ischemic optic neuropathy","score":0.9649999737739563},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.9729999899864197},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8040000200271606},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8360000252723694},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.8820000290870667},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.47999998927116394},{"id":"https://openalex.org/keywords/diabetic-retinopathy","display_name":"diabetic retinopathy","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9305570125579834},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.5716220140457153},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.528954267501831},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.44755083322525024},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.4328889846801758},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4071393311023712},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.2878606915473938},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.24202343821525574},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.16842401027679443},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.1457424759864807}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1111/dom.16076","doi":"https://doi.org/10.1111/dom.16076","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.16076","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.16076","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11701179","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11701179","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11701179/pdf/DOM-27-1005.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"},{"id":"pmid:39563616","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39563616","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Letter"},{"id":"pmh:oai:flore.unifi.it:2158/1403776","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2158/1403776","pdf_url":null,"source":{"id":"https://openalex.org/S4306402033","display_name":"Florence Research (University of Florence)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45084792","host_organization_name":"University of Florence","host_organization_lineage":["https://openalex.org/I45084792"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1111/dom.16076","doi":"https://doi.org/10.1111/dom.16076","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.16076","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.16076","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322648","display_name":"Universit\u00e0 degli Studi di Firenze","ror":"https://ror.org/04jr1s763"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4404547014.pdf","grobid_xml":"https://content.openalex.org/works/W4404547014.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1980569331","https://openalex.org/W2519510391","https://openalex.org/W2802890213","https://openalex.org/W2970684805","https://openalex.org/W3144543375","https://openalex.org/W4378173101","https://openalex.org/W4380729858","https://openalex.org/W4385476384","https://openalex.org/W4386154055","https://openalex.org/W4386877717","https://openalex.org/W4386923470","https://openalex.org/W4388592674","https://openalex.org/W4391844450","https://openalex.org/W4393255879","https://openalex.org/W4398781461","https://openalex.org/W4400281029"],"related_works":["https://openalex.org/W7155213442","https://openalex.org/W4410549513","https://openalex.org/W4410431555","https://openalex.org/W7118504362","https://openalex.org/W7128598885","https://openalex.org/W4407930749","https://openalex.org/W7125981916","https://openalex.org/W7214907749","https://openalex.org/W4412599524","https://openalex.org/W4414620434"],"abstract_inverted_index":{"BACKGROUNDGlucagon-like":[0],"peptide-1":[1],"receptor":[2],"agonists":[3],"(GLP-1":[4],"RA)":[5],"are":[6,26],"an":[7,101],"established":[8],"treatment":[9,31,105],"for":[10,32,63,114],"type":[11],"2":[12,49],"diabetes;":[13],"due":[14],"to":[15,139,148],"their":[16],"weight-reducing":[17],"effect,":[18],"some":[19],"of":[20,23,37,45,53,84,90,100,103,191,209,215,224,226,235],"the":[21,24,82,98,122,131,154,184,213,233],"molecules":[22],"class":[25],"increasingly":[27],"used":[28],"as":[29,130],"a":[30,43,72,85,93,107,136,140,144,188,199],"obesity.":[33],"1":[34],"The":[35],"use":[36],"GLP-1":[38,175],"RA":[39],"is":[40,150,196],"associated":[41],"with":[42,50,75,106,166],"reduction":[44,89],"major":[46],"cardiovascular":[47],"events,":[48],"possible":[51,189],"improvements":[52],"heart":[54],"failure,":[55],"3,4":[56],"and":[57,87,169],"renal":[58],"function.5":[59],"An":[60],"increased":[61],"risk":[62,113],"worsening":[64],"pre-existing":[65],"diabetic":[66],"retinopathy":[67],"was":[68,133],"also":[69],"observed":[70],"in":[71,112,135,153,164,180,183,230],"large":[73],"trial":[74,240],"semaglutide,":[76],"6":[77],"but":[78,121,161],"it":[79],"may":[80],"be":[81,125,219],"consequence":[83],"sudden":[86],"wide":[88],"hyperglycaemia.7":[91],"Recently,":[92],"retrospective":[94,200],"observational":[95,231],"study":[96,132],"highlighted":[97],"possibility":[99,214],"association":[102],"semaglutide":[104],"more":[108,162],"than":[109],"four-fold":[110],"increase":[111],"nonarteritic":[115],"anterior":[116],"ischemic":[117],"optic":[118,194],"neuropathy":[119,195],"(NAION),":[120],"results":[123],"could":[124],"affected":[126],"by":[127],"selection":[128],"bias,":[129],"performed":[134],"sample":[137],"referring":[138],"specialist":[141],"facility.8":[142],"NAION,":[143],"condition":[145],"potentially":[146],"leading":[147],"blindness,":[149],"relatively":[151],"rare":[152],"general":[155],"population":[156],"(2-10/100":[157],"000":[158],"cases/year),":[159],"9,10":[160],"frequent":[163],"patients":[165],"obesity,":[167],"diabetes":[168],"possibly":[170],"obstructive":[171],"sleep":[172],"apnoea.10,11":[173],"Because":[174],"receptors":[176],"have":[177],"been":[178],"detected":[179,229],"neuronal":[181],"cells":[182],"human":[185],"eye,":[186],"12":[187],"effect":[190],"GLP1-RA":[192],"on":[193],"not":[197],"implausible.However,":[198],"study,":[201],"even":[202],"when":[203],"well-designed,":[204],"cannot":[205,218],"provide":[206],"any":[207],"demonstration":[208],"causal":[210],"relationships,":[211],"because":[212],"confounding":[216],"factors":[217],"entirely":[220],"ruled":[221],"out.In":[222],"case":[223],"suggestions":[225],"safety":[227],"issues":[228],"studies,":[232],"retrieval":[234],"specific":[236],"data":[237],"from":[238],"randomised":[239],"can":[241],"therefore":[242],"add":[243],"relevant":[244],"information.":[245]},"counts_by_year":[{"year":2026,"cited_by_count":29},{"year":2025,"cited_by_count":21}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-11-21T00:00:00"}